AtriCure, Inc.
NASDAQ:ATRCMedical - Instruments & Supplies
+$0.96 today
- Market cap
- $2.82B
- Beta
- 1.26
- P/E (TTM)
- -295.5
- EPS (TTM)
- -$0.10
Volume 0.60M
Average 0.77M
ATRC Change in Working Capital
Cash absorbed or released by changes in receivables, inventory, payables, and other operating balances.
AtriCure, Inc.NASDAQ: ATRC
Change in Working Capital · Q2 FY2026 · quarter ended Jun 2026
Change in working capital turns negative
Q2 FY2026 change in working capital was -$4.42M, compared with $6.33M a year earlier. Trailing-twelve-month change in working capital was -$16.89M. Over 3 fiscal years it compounded at -39.0% a year.
Context
- Change in working capital amounted to 0.8% of revenue in FY2025, down 3.1 pp from a year earlier.
- Change in working capital grew in size in 1 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly change in working capital holds near -$4.42M or moves back toward the trailing-twelve-month quarterly average of -$4.22M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Change in Working Capital history
USD · from the cash flow
- Latest · FY2025
- (4.29M) USD
- Year-over-year change
- +76.7%
| Period | Period end | Change in Working Capital | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (4.29M) | +76.7% |
| FY2024 | 2024-12-31 | (18.36M) | -0.6% |
| FY2023 | 2023-12-31 | (18.24M) | +3.4% |
| FY2022 | 2022-12-31 | (18.88M) | -289.6% |
| FY2021 | 2021-12-31 | (4.85M) | — |
Change in Working Capital vs competitors
How ATRC compares with its peers on the latest reported figures
- ATRC's LTM Jun 2026 change in working capital of $16.89M is the smallest of the 5 companies compared; the peer median is $341.8M.
- Its year-over-year change of +101.1% is the highest of 5, against a peer median of -175.6%.
- Change in working capital amounts to 3.0% of revenue for ATRC, versus a peer median of 2.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jul 2026 | $941M | -240.4% | +13.7% | 2.5% | |
| LTM Jun 2026 | $642M | -1526.7% | -37.4% | 3.1% | |
| LTM Sep 2026 | $41.59M | -110.8% | — | 2.8% | |
| LTM Jun 2026 | $31.8M | -55.8% | — | 0.5% | |
| LTM Jun 2026 | $16.89M | +101.1% | -39.0% | 3.0% | |
| Peer median (excluding ATRC) | $341.8M | -175.6% | -11.9% | 2.6% | |
Competitors are the stored peer set for ATRC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 50.2M | (46.47M) | (30.44M) | (44.7M) | (11.45M) |
| Depreciation & Amortization | 10.44M | 11.71M | 14.81M | 18.73M | 20.53M |
| Deferred Income Tax | 84.78M | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 28.08M | 28.77M | 35.73M | 40.41M | 44.69M |
| Change in Working Capital | (4.85M) | (18.88M) | (18.24M) | (18.36M) | (4.29M) |
| Accounts Receivables | (10.09M) | (8.99M) | (9.87M) | (8.3M) | (5.61M) |
| Inventory | (4.27M) | (7.31M) | (21.83M) | (7.74M) | (2.26M) |
| Accounts Payables | 4.71M | 2.68M | 6.18M | (1.53M) | (960K) |
| Other Working Capital | 4.81M | (5.26M) | 7.29M | (786K) | 4.54M |
| Other Non-Cash Items | (182.43M) | 2.72M | 2.62M | 16.12M | 7.85M |
| Operating Cash Flow | (13.78M) | (22.14M) | 4.48M | 12.2M | 57.33M |
| Capital Expenditures | (9.75M) | (16.88M) | (42M) | (23.46M) | (9.05M) |
| Acquisitions (Net) | (33.26M) | (44.01M) | 0 | 0 | 0 |
| Purchases of Investments | (173.11M) | (24.64M) | 0 | 0 | 0 |
| Sales of Investments | 206.36M | 85.52M | 63.82M | 0 | 0 |
| Other Investing Activities | 33.26M | 44.01M | (30M) | 41.69M | (5.5M) |
| Investing Cash Flow | 23.5M | 44.01M | 21.82M | 30.23M | (14.55M) |
| Debt Repayment | (816K) | (899K) | (992K) | (1.67M) | 5.05M |
| Common Stock Issued | 0 | 0 | 0 | 0 | 7.29M |
| Common Stock Repurchased | (18.01M) | (12.2M) | (6.56M) | (6.95M) | (11.16M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 11.19M | 6.04M | 7.52M | 5.02M | 0 |
| Financing Cash Flow | (7.64M) | (7.06M) | (32K) | (3.6M) | 1.18M |
| Effect of Forex Changes | (372K) | (361K) | (58K) | (424K) | 747K |
| Net Change in Cash | 1.71M | 14.45M | 26.21M | 38.41M | 44.71M |
| Free Cash Flow | (23.53M) | (39.02M) | (37.51M) | (11.26M) | 48.28M |
AtriCure, Inc.
NASDAQ:ATRC
Intrinsic Alpha fair value
Locked
Current Price
$55.45
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.